The Sichuan Pharmaceutical Machinery Collection Center renewed its power and demanded that six companies that were reported by real-name companies to clarify or sign the report for a limited period of time, otherwise the products would be kicked out of the market.
On April 26, the Sichuan Provincial Medicines and Drugs Centralized Purchasing Service Center issued a notice stating that the Center received a real-name questioning material about the reference price information of some high-value medical consumable products.
According to the notification requirements, the enterprise manager involved in the materials must carry a power of attorney to the center to sign the relevant challenge information before 17:00 on May 9 or submit the clarification (certification) materials on site. Enterprises that fail to sign or confirm or submit clarification materials will be suspended from the relevant products.
In this notice, there are always six companies involved in real-name questioning materials: Shanghai Weichuang Medical Devices (Group) Co., Ltd., Bard Medical Technology (Shanghai) Co., Ltd., Youyan Yijin New Materials Co., Ltd., Johnson & Johnson (Shanghai Medical Devices Co., Ltd., Shanghai Changdao Medical Equipment Co., Ltd., Medtronic (Shanghai) Management Co., Ltd. The world's three major medical equipment, as well as the domestic leader Shanghai Micro-creative are listed.
This is also the third time in this week that the Sichuan Pharmaceutical Machinery Collection Center has relied on the reference price information for high-value consumables.
On April 20th, the Center issued a notice stating that in March 2017, it received a real-name questioning material about the reference price information of some high-value medical consumable products.
Xianjian Technology was reported by real name and did not submit the reference price update materials to the center in time. To this end, some of the relevant products of the enterprise have been disqualified from the network, and they will no longer accept applications for network registration within one year, and will not be allowed to enter the province to purchase medical institutions in a centralized manner; and some related products are ordered to lower the actual minimum reference price by 10% as a self-quotation. .
On the same day (April 20), the Center issued a notice stating that in the second round of 2016, the reference price information for some of the high-value consumable products to be linked to the network was added and added, and the objection materials were received during the publicity period. The manager of the relevant company must also sign or confirm the objection information by 17:00 on May 3, 2017.
In this notice, there are 73 companies that have objection to the price information, including:
API Products
Shandong YingLang Chemical Co.,Ltd , https://www.sdylhgtrade.com